Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Evaluation of the tumor movement and the reproducibility of two different immobilization setups for image-guided stereotactic body radiotherapy of liver tumors.

Dreher C, Oechsner M, Mayinger M, Beierl S, Duma MN, Combs SE, Habermehl D.

Radiat Oncol. 2018 Jan 30;13(1):15. doi: 10.1186/s13014-018-0962-9.

2.

Deep-Inspiration Breath-Hold Radiation Therapy in Breast Cancer: A Word of Caution on the Dose to the Axillary Lymph Node Levels.

Borm KJ, Oechsner M, Combs SE, Duma MN.

Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):263-269. doi: 10.1016/j.ijrobp.2017.09.026. Epub 2017 Sep 20.

PMID:
29066123
3.

Time for standardization of SBRT planning through large scale clinical data and guideline-based approaches.

Moustakis C, Blanck O, Ebrahimi F, Ka Heng Chan M, Ernst I, Krieger T, Duma MN, Oechsner M, Ganswindt U, Heinz C, Alheit H, Blank H, Nestle U, Wiehle R, Kornhuber C, Ostheimer C, Petersen C, Pollul G, Baus W, Altenstein G, Beckers E, Jurianz K, Sterzing F, Kretschmer M, Seegenschmiedt H, Maass T, Droege S, Wolf U, Schoeffler J, Haverkamp U, Eich H, Guckenberger M.

Strahlenther Onkol. 2017 Dec;193(12):1068-1069. doi: 10.1007/s00066-017-1216-8. Epub 2017 Sep 15. No abstract available.

PMID:
28916902
4.

Are heart toxicities in breast cancer patients important for radiation oncologists? A practice pattern survey in German speaking countries.

Duma MN, Münch S, Oechsner M, Combs SE.

BMC Cancer. 2017 Aug 23;17(1):563. doi: 10.1186/s12885-017-3548-2.

5.

Interobserver variability of patient positioning using four different CT datasets for image registration in lung stereotactic body radiotherapy.

Oechsner M, Chizzali B, Devecka M, Münch S, Combs SE, Wilkens JJ, Duma MN.

Strahlenther Onkol. 2017 Oct;193(10):831-839. doi: 10.1007/s00066-017-1184-z. Epub 2017 Jul 19.

PMID:
28726056
6.

Interobserver variability in target volume delineation of hepatocellular carcinoma : An analysis of the working group "Stereotactic Radiotherapy" of the German Society for Radiation Oncology (DEGRO).

Gkika E, Tanadini-Lang S, Kirste S, Holzner PA, Neeff HP, Rischke HC, Reese T, Lohaus F, Duma MN, Dieckmann K, Semrau R, Stockinger M, Imhoff D, Kremers N, Häfner MF, Andratschke N, Nestle U, Grosu AL, Guckenberger M, Brunner TB.

Strahlenther Onkol. 2017 Oct;193(10):823-830. doi: 10.1007/s00066-017-1177-y. Epub 2017 Jul 10.

PMID:
28695316
7.

Primary radio(chemo)therapy for esophageal cancer in elderly patients: are efficiency and toxicity comparable with younger patients?

Münch S, Heinrich C, Habermehl D, Oechsner M, Combs SE, Duma MN.

Eur J Med Res. 2017 Jul 6;22(1):24. doi: 10.1186/s40001-017-0265-x.

8.

Tangential Field Radiotherapy for Breast Cancer-The Dose to the Heart and Heart Subvolumes: What Structures Must Be Contoured in Future Clinical Trials?

Duma MN, Herr AC, Borm KJ, Trott KR, Molls M, Oechsner M, Combs SE.

Front Oncol. 2017 Jun 19;7:130. doi: 10.3389/fonc.2017.00130. eCollection 2017.

9.

Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy.

Moustakis C, Blanck O, Ebrahimi Tazehmahalleh F, Ka Heng Chan M, Ernst I, Krieger T, Duma MN, Oechsner M, Ganswindt U, Heinz C, Alheit H, Blank H, Nestle U, Wiehle R, Kornhuber C, Ostheimer C, Petersen C, Pollul G, Baus W, Altenstein G, Beckers E, Jurianz K, Sterzing F, Kretschmer M, Seegenschmiedt H, Maass T, Droege S, Wolf U, Schoeffler J, Haverkamp U, Eich HT, Guckenberger M.

Strahlenther Onkol. 2017 Oct;193(10):780-790. doi: 10.1007/s00066-017-1151-8. Epub 2017 May 31.

PMID:
28567503
10.

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT).

Habl G, Straube C, Schiller K, Duma MN, Oechsner M, Kessel KA, Eiber M, Schwaiger M, Kübler H, Gschwend JE, Combs SE.

BMC Cancer. 2017 May 22;17(1):361. doi: 10.1186/s12885-017-3341-2.

11.

Heart-sparing radiotherapy in patients with breast cancer: What are the techniques used in the clinical routine?: A pattern of practice survey in the German-speaking countries.

Duma MN, Münch S, Oechsner M, Combs SE.

Med Dosim. 2017 Autumn;42(3):197-202. doi: 10.1016/j.meddos.2017.03.002. Epub 2017 May 11.

PMID:
28502653
12.

Effects of definitive and salvage radiotherapy on the distribution of lymphocyte subpopulations in prostate cancer patients.

Sage EK, Schmid TE, Geinitz H, Gehrmann M, Sedelmayr M, Duma MN, Combs SE, Multhoff G.

Strahlenther Onkol. 2017 Aug;193(8):648-655. doi: 10.1007/s00066-017-1144-7. Epub 2017 May 12.

PMID:
28500490
13.

Helical TomoTherapy for locally advanced or recurrent breast cancer.

Duma MN, Heinrich C, Schönknecht C, Chizzali B, Mayinger M, Devecka M, Kampfer S, Combs SE.

Radiat Oncol. 2017 Jan 28;12(1):31. doi: 10.1186/s13014-016-0736-1.

14.
15.

Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.

Münch S, Aichmeier S, Hapfelmeier A, Duma MN, Oechsner M, Feith M, Combs SE, Habermehl D.

Strahlenther Onkol. 2016 Oct;192(10):722-9. doi: 10.1007/s00066-016-1020-x. Epub 2016 Jul 14.

PMID:
27418129
16.

Oral squamous cell carcinoma: the impact of stage-dependent therapy regimes on postoperative disease recurrence.

Unterhuber T, Duma MN, Rau A, Nieberler M, Wolff KD, Kesting MR.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Feb;121(2):133-8. doi: 10.1016/j.oooo.2015.10.004. Epub 2015 Oct 22.

PMID:
26711710
17.

Comparative analysis of the effects of radiotherapy versus radiotherapy after adjuvant chemotherapy on the composition of lymphocyte subpopulations in breast cancer patients.

Sage EK, Schmid TE, Sedelmayr M, Gehrmann M, Geinitz H, Duma MN, Combs SE, Multhoff G.

Radiother Oncol. 2016 Jan;118(1):176-80. doi: 10.1016/j.radonc.2015.11.016. Epub 2015 Dec 9.

PMID:
26683801
18.

Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy.

Oechsner M, Odersky L, Berndt J, Combs SE, Wilkens JJ, Duma MN.

Radiat Oncol. 2015 Dec 1;10:249. doi: 10.1186/s13014-015-0557-7.

19.

Implications of free breathing motion assessed by 4D-computed tomography on the delivered dose in radiotherapy for esophageal cancer.

Duma MN, Berndt J, Rondak IC, Devecka M, Wilkens JJ, Geinitz H, Combs SE, Oechsner M.

Med Dosim. 2015 Winter;40(4):378-82. doi: 10.1016/j.meddos.2015.07.002. Epub 2015 Sep 26.

PMID:
26419857
20.

An expression analysis of markers of radiation-induced skin fibrosis and angiogenesis in wound healing disorders of the head and neck.

Koerdt S, Rohleder NH, Rommel N, Nobis C, Stoeckelhuber M, Pigorsch S, Duma MN, Wolff KD, Kesting MR.

Radiat Oncol. 2015 Sep 22;10:202. doi: 10.1186/s13014-015-0508-3.

21.

The importance of surrounding tissues and window settings for contouring of moving targets.

Borm KJ, Oechsner M, Berndt J, Combs SE, Molls M, Duma MN.

Strahlenther Onkol. 2015 Sep;191(9):750-6. doi: 10.1007/s00066-015-0862-y. Epub 2015 Jun 19.

PMID:
26087909
22.

Long-term survival in metastasized leiomyosarcoma: a case report and review of the literature.

Schönknecht C, Hadjamu M, Oechsner M, Andratschke N, Duma MN.

Tumori. 2015 Sep 9;101(5):e141-4. doi: 10.5301/tj.5000310. Review.

PMID:
26045119
23.

Impact of interfractional changes in head and neck cancer patients on the delivered dose in intensity modulated radiotherapy with protons and photons.

Müller BS, Duma MN, Kampfer S, Nill S, Oelfke U, Geinitz H, Wilkens JJ.

Phys Med. 2015 May;31(3):266-72. doi: 10.1016/j.ejmp.2015.02.007. Epub 2015 Feb 25.

24.

The impact of CT window settings on the contouring of a moving target: A phantom study.

Borm KJ, Oechsner M, Wilkens JJ, Berndt J, Molls M, Geinitz H, Duma MN.

Clin Radiol. 2014 Aug;69(8):e331-6. doi: 10.1016/j.crad.2014.03.006. Epub 2014 May 10. No abstract available.

PMID:
24821318
25.

Impact of different setup approaches in image-guided radiotherapy as primary treatment for prostate cancer: a study of 2940 setup deviations in 980 MVCTs.

Schiller K, Petrucci A, Geinitz H, Schuster T, Specht H, Kampfer S, Duma MN.

Strahlenther Onkol. 2014 Aug;190(8):722-6. doi: 10.1007/s00066-014-0629-x. Epub 2014 Apr 23.

PMID:
24756138
26.

Protection of quality and innovation in radiation oncology: the prospective multicenter trial QUIRO of DEGRO: evaluation of time, attendance of medical staff, and resources during radiotherapy with tomotherapy.

Winkler C, Duma MN, Popp W, Sack H, Budach V, Molls M, Kampfer S.

Strahlenther Onkol. 2014 Oct;190(10):950-6. doi: 10.1007/s00066-014-0615-3. Epub 2014 Mar 22.

PMID:
24658604
27.

From heart to heart for breast cancer patients - cardiovascular toxicities in breast cancer radiotherapy.

Duma MN, Molls M, Trott KR.

Strahlenther Onkol. 2014 Jan;190(1):5-7. doi: 10.1007/s00066-013-0465-4. Epub 2013 Nov 21. No abstract available.

PMID:
24253182
28.

A novel setup approach for helical tomotherapy in head and neck cancer: A case report.

Duma MN, Geinitz H, Kampfer S, Kesting MR.

Oncol Lett. 2013 Nov;6(5):1470-1474. Epub 2013 Sep 2.

29.

Localization and quantification of the delivered dose to the spinal cord. Predicting actual delivered dose during daily MVCT image-guided tomotherapy.

Duma MN, Schuster T, Aswathanarayana N, Fromm LS, Molls M, Geinitz H, Kampfer S.

Strahlenther Onkol. 2013 Dec;189(12):1026-31. doi: 10.1007/s00066-013-0436-9. Epub 2013 Oct 10.

PMID:
24104870
30.

Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.

Bundschuh RA, Andratschke N, Dinges J, Duma MN, Astner ST, Brügel M, Ziegler SI, Molls M, Schwaiger M, Essler M.

Strahlenther Onkol. 2012 Jul;188(7):592-8. doi: 10.1007/s00066-012-0094-3. Epub 2012 Mar 24.

PMID:
22441441
31.

Do we need daily image-guided radiotherapy by megavoltage computed tomography in head and neck helical tomotherapy? The actual delivered dose to the spinal cord.

Duma MN, Kampfer S, Schuster T, Aswathanarayana N, Fromm LS, Molls M, Andratschke N, Geinitz H.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):283-8. doi: 10.1016/j.ijrobp.2011.10.073. Epub 2012 Mar 13.

PMID:
22417803
32.

Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy.

Geier M, Astner ST, Duma MN, Jacob V, Nieder C, Putzhammer J, Winkler C, Molls M, Geinitz H.

Strahlenther Onkol. 2012 May;188(5):410-6. doi: 10.1007/s00066-012-0081-8. Epub 2012 Feb 26.

PMID:
22367410
33.

Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer.

Duma MN, Kampfer S, Schuster T, Winkler C, Geinitz H.

Strahlenther Onkol. 2012 Mar;188(3):243-7. doi: 10.1007/s00066-011-0041-8.

PMID:
22294198
34.

Measurements to predict the time of target replacement of a helical tomotherapy.

Kampfer S, Schell S, Duma MN, Wilkens JJ, Kneschaurek P.

J Appl Clin Med Phys. 2011 Nov 15;12(4):3596. doi: 10.1120/jacmp.v12i4.3596.

PMID:
22089018
35.

Comparative analysis of an image-guided versus a non-image-guided setup approach in terms of delivered dose to the parotid glands in head-and-neck cancer IMRT.

Duma MN, Kampfer S, Wilkens JJ, Schuster T, Molls M, Geinitz H.

Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1266-73. doi: 10.1016/j.ijrobp.2009.09.047. Epub 2010 Mar 28.

PMID:
20350787
36.

Measles in hospitalized African children with human immunodeficiency virus.

Sension MG, Quinn TC, Markowitz LE, Linnan MJ, Jones TS, Francis HL, Nzilambi N, Duma MN, Ryder RW.

Am J Dis Child. 1988 Dec;142(12):1271-2. No abstract available.

PMID:
3195521

Supplemental Content

Support Center